Gene therapy for hereditary retinoblastoma (CRISPR-Cas9)

Type: gene_therapy

Status: Investigational

Developer: Children's Hospital Los Angeles

Breakthrough Summary

No summary available.

Mechanism of Action

Details pending.

Year: 2026